Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMothercare Regulatory News (MTC)

Share Price Information for Mothercare (MTC)

Share Price is delayed by 15 minutes
Get Live Data
1.00    0.00 (0.00%)
Bid:
0.75
Ask:
1.25
Spread: 0.50 (66.667%)
Market Cap: £5.64m
MTC Live PriceLast checked at - London Stock Exchange

Intraday Mothercare Share Chart

Pre-close trading update

13 Apr 2026 07:00

Pre-close trading update
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART, IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

Mothercare plc

Pre-close trading update

Mothercare plc ("Mothercare" or "the Company"), the leading specialist global brand for parents and young children, today issues a pre-close trading update for the 52 week period to 28 March 2026 (“FY26”). Comparatives are based on the 52 week period to 29 March 2025. This update is based upon draft figures pending finalisation of the year end audit.

• Unaudited worldwide retail sales by franchise partners of £180 million for the year, representing a decline of 22% on last year (19% down at constant currency)

• Adjusted EBITDA for FY26 at approximately £1.25 million

• Net borrowings of £5.7 million at the year end (March 2025: £3.7 million).

• Pension scheme deficit remains at £35 million as at 31 December 2025, which is the latest available estimate (March 2025: £35 million) on a technical provisions basis.

The performance reflects variously the end of our exclusive distribution relationship with Boots at the end of 2025, foreign exchange rate impacts and the longstanding uncertainty in our Middle Eastern markets, including the more recent impact of the Iran war in the last month of the period.

EBITDA before adjusting items for FY26, is now expected to be approximately £1.25 million, compared to the £3.5 million adjusted EBITDA for the period to March 2025. We estimate that the impact of the war in the Middle East, in the last month of the period under review, to be approximately £0.1m.

The underlying strength of the business is demonstrated by the fact that excluding the Middle East and the UK, where we continue to believe that there remains a greater opportunity for the brand and a new partner in the UK, on a like for like basis our total retail sales were positive for the full year to March 2026.

There has been no material change to the Group’s financial position since the announcement made on 20 February 2026, setting out the successful and timely refinancing of the Group’s debt facilities and the deferral of contributions to the Group’s pension schemes.

Clive Whiley, Chairman of Mothercare, commented:

“Our results for last year reflect the impact of the continuing uncertainty on our franchise partners’ operations in the Middle East, where any longer-term impact upon supply chains remains unclear at this stage, and the underlying profitability and cash generation of our asset-light franchise system.

The full refinancing of our debt facilities in February 2026 has bought additional time to engineer a more comprehensive solution to harvest the value of the brand IP and the significant operational gearing available to an expanded business. In these circumstances the recent financial performance has been usefully resilient as we look to FY27, whilst acknowledging the impact of the continuing disruption from events in the Middle East.

Given the external factors influencing some of the Company’s key operating markets, our immediate priority remains to support our franchise partners, ultimately for the benefit of our own underlying business, where the strength of the Mothercare brand endures. We remain in discussions with several parties to restore critical mass, a process greatly assisted by the recent alignment of the first-charge debt instrument with our equity.

I would like to thank all of our colleagues and stakeholders for their support and efforts in difficult circumstances, and the board remains determined to optimise the brand IP for the benefit of all stakeholders.“

Investor and analyst enquiries to:

Mothercare plc  Email: investorrelations@mothercare.comClive Whiley, ChairmanAndrew Cook, Chief Financial Officer Deutsche Numis Tel: 020 7260 1000(NOMAD & Joint Corporate Broker)  Luke BordewichAneesh Oza

Cavendish Capital Markets Limited  Tel: 020 7220 0500(Joint Corporate Broker) 

Matt Goode

This announcement contains information that is inside information for the purposes of Article 7 of the UK version of Regulation (EU) No. 596/2014 which is part of UK law by virtue of the European Union (Withdrawal) Act 2018, as amended (the Market Abuse Regulation ("MAR")). Upon the publication of this announcement, such information will no longer constitute inside information. Andrew Cook, the Company's CFO, is the person responsible for making the notification for the purposes of Article 17 of MAR.

Date   Source Headline
25th Mar 20214:35 pmRNSPrice Monitoring Extension
18th Mar 20214:04 pmGNWHolding(s) in Company
18th Mar 20213:59 pmGNWHolding(s) in Company
18th Mar 20212:34 pmGNWHolding(s) in Company
18th Mar 20212:07 pmGNWHolding(s) in Company
18th Mar 20212:04 pmGNWHolding(s) in Company
16th Mar 20211:30 pmGNWCompletion of the CULS Arrangements and Related Party Transactions
12th Mar 20217:00 amGNWAdmission to AIM
11th Mar 20212:51 pmGNWBlock listing application
5th Mar 20216:00 pmRNSMothercare
19th Feb 20214:41 pmRNSSecond Price Monitoring Extn
19th Feb 20214:36 pmRNSPrice Monitoring Extension
11th Feb 20218:00 amRNSAppendix to Schedule One Announcement
11th Feb 20218:00 amRNSSchedule One - Mothercare PLC
10th Feb 202112:45 pmRNSResult of General Meeting
8th Feb 20215:15 pmRNSHolding(s) in Company
27th Jan 20211:41 pmRNSHolding(s) in Company
25th Jan 20217:00 amRNSDelisting and Notice of General Meeting
15th Jan 20214:47 pmRNSHolding(s) in Company
23rd Dec 202012:00 pmRNSDirector/PDMR Shareholding
21st Dec 20207:00 amRNSBlock listing Interim Review
26th Nov 20201:15 pmRNSGeneral Meeting Results
26th Nov 20208:30 amRNSHalf Year Results
28th Oct 20207:15 amRNSNotice of General Meeting
1st Oct 20207:00 amRNSDirector/PDMR Shareholdings
25th Sep 202010:30 amRNSANNUAL REPORT AND FINANCIAL STATEMENTS
25th Sep 20207:00 amRNSFinal Results
23rd Sep 20203:30 pmRNSResult of AGM
24th Aug 202011:58 amGNWNotice of AGM
20th Aug 20207:00 amGNWFurther re Transformation Plan Update
5th Aug 20204:40 pmRNSSecond Price Monitoring Extn
5th Aug 20204:36 pmRNSPrice Monitoring Extension
27th Jul 20204:40 pmRNSSecond Price Monitoring Extn
27th Jul 20204:35 pmRNSPrice Monitoring Extension
24th Jul 202010:23 amGNWDirectorate change
7th Jul 20204:35 pmRNSPrice Monitoring Extension
6th Jul 20204:41 pmRNSSecond Price Monitoring Extn
6th Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20204:40 pmRNSSecond Price Monitoring Extn
2nd Jul 20204:36 pmRNSPrice Monitoring Extension
29th Jun 20204:41 pmRNSSecond Price Monitoring Extn
29th Jun 20204:35 pmRNSPrice Monitoring Extension
24th Jun 20204:42 pmRNSSecond Price Monitoring Extn
24th Jun 20204:37 pmRNSPrice Monitoring Extension
22nd Jun 20201:26 pmGNWBlock listing Interim Review
22nd Jun 20207:00 amRNSTransformation Plan Update
11th Jun 20203:48 pmGNWDirector Declaration
1st Jun 20204:41 pmRNSSecond Price Monitoring Extn
1st Jun 20204:36 pmRNSPrice Monitoring Extension
27th May 20204:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.